- Home
- MNDO vs ANTX Comparison
MNDO vs ANTX Comparison
Compare MNDO & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- ANTX
- Stock Information
- Founded
- MNDO 1995
- ANTX 2017
- Country
- MNDO Israel
- ANTX United States
- Employees
- MNDO N/A
- ANTX N/A
- Industry
- MNDO EDP Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- ANTX Health Care
- Exchange
- MNDO Nasdaq
- ANTX Nasdaq
- Market Cap
- MNDO 40.2M
- ANTX 40.0M
- IPO Year
- MNDO 2000
- ANTX 2022
- Fundamental
- Price
- MNDO $2.01
- ANTX $1.32
- Analyst Decision
- MNDO
- ANTX Hold
- Analyst Count
- MNDO 0
- ANTX 5
- Target Price
- MNDO N/A
- ANTX $3.50
- AVG Volume (30 Days)
- MNDO 20.9K
- ANTX 833.6K
- Earning Date
- MNDO 11-05-2024
- ANTX 11-13-2024
- Dividend Yield
- MNDO 12.01%
- ANTX N/A
- EPS Growth
- MNDO N/A
- ANTX N/A
- EPS
- MNDO 0.23
- ANTX N/A
- Revenue
- MNDO $21,856,000.00
- ANTX N/A
- Revenue This Year
- MNDO N/A
- ANTX N/A
- Revenue Next Year
- MNDO N/A
- ANTX N/A
- P/E Ratio
- MNDO $8.72
- ANTX N/A
- Revenue Growth
- MNDO 2.27
- ANTX N/A
- 52 Week Low
- MNDO $1.70
- ANTX $0.87
- 52 Week High
- MNDO $2.28
- ANTX $22.22
- Technical
- Relative Strength Index (RSI)
- MNDO 52.28
- ANTX 50.02
- Support Level
- MNDO $1.95
- ANTX $1.32
- Resistance Level
- MNDO $2.04
- ANTX $1.59
- Average True Range (ATR)
- MNDO 0.04
- ANTX 0.09
- MACD
- MNDO 0.00
- ANTX -0.03
- Stochastic Oscillator
- MNDO 55.56
- ANTX 7.89
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.